Haider Alkhateeb is a Cardiology physician affiliated with Texas Tech University. OpenAlex indexes 43 publications with 217 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4801 Alberta Ave
El Paso, TX 79905
Telephone
915-215-5200Provider last certified this registry record 6 Mar 2026.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Boston Scientific CorporationProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85%Statin23.8%Atorvastatin Calcium61%Rosuvastatin Calcium39%Part D≥18 patientsBeta blocker22.8%Metoprolol Tartrate41%Carvedilol32%Metoprolol Succinate27%Part D<11 patients+ 4 more classes in this area
Blood & clotting
8.3%Factor Xa inhibitor8.3%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
6.7%SGLT2 inhibitor6.7%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Updates in the Pharmacotherapy of Pulmonary Hypertension in Patientswith Heart Failure with Preserved Ejection Fraction
Cardiovascular & Haematological Disorders - Drug Targets
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Debabrata Mukherjee, MD
Texas Tech University
Kenneth Nugent, MD
Texas Tech University
Javier Corral, MD
Texas Tech University
Marc Zuckerman, MD
Texas Tech University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”